Tanvex BioPharma, Inc. (6541.TW) TAI

56.20

-0.6(-1.06%)

Updated at December 05 12:59PM

Currency In TWD

Valuation

Market Cap10.12B
Enterprise Value11.39B
P/E Ratio-9.67
PEG Ratio-0.88
Price/Sales Ratio135.76
Price/Book Ratio2.78
Enterprise/Revenue144.44
Enterprise/EBITDA-15.73

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-12.64
Operating Margin-11.77

Management Effectiveness

Return On Assets-0.2
Return On Equity-0.45

Income Statement

Revenue34.68M
Revenue/Share0.47
Gross Profit8.29M
EBITDA-1.04B
Net Income-1.38B
Diluted EPS-8.9

Balance Sheet

Total Cash570.97M
Total Cash/Share2.4
Total Debt1.54B
Total Debt/Equity0.32
Current Ratio2.17
Book Value Per Share20.45

Price History

52-Week Change-21.3
52-Week High82
52-Week Low48.1
Moving Average 50 Days55.4
Moving Average 200 Days57.49

Statistics

Average Volume975,867
Shares Outstanding264.82M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor51:50
Last Split DateMarch 27, 2023